196 related articles for article (PubMed ID: 6418205)
41. Differential regulation of platelet aggregation and aminophospholipid exposure by calpain.
Bachelot-Loza C; Badol P; Brohard-Bohn B; Fraiz N; Cano E; Rendu F
Br J Haematol; 2006 May; 133(4):419-26. PubMed ID: 16643450
[TBL] [Abstract][Full Text] [Related]
42. Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism.
Martinson EA; Scheible S; Greinacher A; Presek P
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):623-8. PubMed ID: 7544577
[TBL] [Abstract][Full Text] [Related]
43. Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets.
Briedé JJ; Heemskerk JW; van't Veer C; Hemker HC; Lindhout T
Thromb Haemost; 2001 Mar; 85(3):509-13. PubMed ID: 11307823
[TBL] [Abstract][Full Text] [Related]
44. The mobilization of arachidonic acid in platelets exposed to thrombin or ionophore A23187. Effects of adenosine triphosphate deprivation.
Rittenhouse-Simmons S; Deykin D
J Clin Invest; 1977 Aug; 60(2):495-8. PubMed ID: 326813
[TBL] [Abstract][Full Text] [Related]
45. Bacterial cytotoxins, amphotericin B and local anesthetics enhance transbilayer mobility of phospholipids in erythrocyte membranes. Consequences for phospholipid asymmetry.
Schneider E; Haest CW; Plasa G; Deuticke B
Biochim Biophys Acta; 1986 Mar; 855(3):325-36. PubMed ID: 3081027
[TBL] [Abstract][Full Text] [Related]
46. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.
Andersen H; Greenberg DL; Fujikawa K; Xu W; Chung DW; Davie EW
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11189-93. PubMed ID: 10500152
[TBL] [Abstract][Full Text] [Related]
47. Acceleration by ceramide of calcium-dependent translocation of phospholipase A2 from cytosol to membranes in platelets.
Kitatani K; Oka T; Murata T; Hayama M; Akiba S; Sato T
Arch Biochem Biophys; 2000 Oct; 382(2):296-302. PubMed ID: 11068881
[TBL] [Abstract][Full Text] [Related]
48. Human platelet phospholipase A2 activity is responsive in vitro to pH and Ca2+ variations which parallel those occurring after platelet activation in vivo.
Baron BM; Limbird LE
Biochim Biophys Acta; 1988 Aug; 971(1):103-11. PubMed ID: 3408741
[TBL] [Abstract][Full Text] [Related]
49. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
Schafer AI; Adelman B
J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
51. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
Teng CM; Ma YH; Ouyang CH
Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
[TBL] [Abstract][Full Text] [Related]
52. Asymmetric distribution of arachidonic acid in the plasma membrane of human platelets. A determination using purified phospholipases and a rapid method for membrane isolation.
Perret B; Chap HJ; Douste-Blazy L
Biochim Biophys Acta; 1979 Oct; 556(3):434-46. PubMed ID: 486472
[TBL] [Abstract][Full Text] [Related]
53. Loss of phospholipid asymmetry in human platelet plasma membrane after 1-12 days of storage. An ESR study.
Gaffet P; Bassé F; Bienvenüe A
Eur J Biochem; 1994 Jun; 222(3):1033-40. PubMed ID: 8026481
[TBL] [Abstract][Full Text] [Related]
54. The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions.
Biró E; Akkerman JW; Hoek FJ; Gorter G; Pronk LM; Sturk A; Nieuwland R
J Thromb Haemost; 2005 Dec; 3(12):2754-63. PubMed ID: 16359513
[TBL] [Abstract][Full Text] [Related]
55. Ionophore A-23187- and thrombin-induced platelet aggregation: independence from cycloxygenase products.
Lapetina EG; Chandrabose KA; Cuatrecasas P
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):818-22. PubMed ID: 204935
[TBL] [Abstract][Full Text] [Related]
56. Phospholipase A2-catalyzed hydrolysis of plasmalogen phospholipids in thrombin-stimulated human platelets.
Beckett CS; Kell PJ; Creer MH; McHowat J
Thromb Res; 2007; 120(2):259-68. PubMed ID: 17055038
[TBL] [Abstract][Full Text] [Related]
57. Activation of phospholipase A2 and beta-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation.
Stasi M; Gresele P; Porcellati S; Quero E; Nenci GG; Goracci G
Biochim Biophys Acta; 1992 Mar; 1124(3):279-87. PubMed ID: 1315576
[TBL] [Abstract][Full Text] [Related]
58. Characterization of sphingomyelinase activity released by thrombin-stimulated platelets.
Romiti E; Vasta V; Meacci E; Farnararo M; Linke T; Ferlinz K; Sandhoff K; Bruni P
Mol Cell Biochem; 2000 Feb; 205(1-2):75-81. PubMed ID: 10821424
[TBL] [Abstract][Full Text] [Related]
59. D-galactosamine induced changes in rat liver plasma membranes lipid composition and some enzyme activities.
Petkova DH; Momchilova AB; Markovska TT; Koumanov KS
Int J Biochem; 1987; 19(3):289-91. PubMed ID: 3036613
[TBL] [Abstract][Full Text] [Related]
60. Altered phospholipid composition of plasma membranes from thrombin-stimulated human platelets.
Skeaff CM; Holub BJ
Biochim Biophys Acta; 1985 Apr; 834(2):164-71. PubMed ID: 3995060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
